- Markets
- Healthcare
- ORTINGLOBE
ORTINGLOBE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Ortin Laboratories Approves Sale Of Undertaking/Total Property Of Co At Telangana
Nov 14 (Reuters) - Ortin Laboratories Ltd ORTN.NS:
ORTIN LABORATORIES LTD - APPROVED SALE OF UNDERTAKING/TOTAL PROPERTY OF CO AT TELANGANA
Source text for Eikon: ID:nNSE1bsr4D
Further company coverage: ORTN.NS
(([email protected];;))
Nov 14 (Reuters) - Ortin Laboratories Ltd ORTN.NS:
ORTIN LABORATORIES LTD - APPROVED SALE OF UNDERTAKING/TOTAL PROPERTY OF CO AT TELANGANA
Source text for Eikon: ID:nNSE1bsr4D
Further company coverage: ORTN.NS
(([email protected];;))
Ortin Laboratories Says Drugs Control Administration, Government Of Telangana Cancelled Co’S Manufacturing License
July 11 (Reuters) - Ortin Laboratories Ltd ORTN.NS:
DRUGS CONTROL ADMINISTRATION, GOVERNMENT OF TELANGANA CANCELLED CO’S MANUFACTURING LICENSE
CANCELLATION FORWANT OF UPGRADATION OF MANUFACTURING FACILITIES, INFRASTRUCTURE AND RECRUITING EXPERT TECHNICAL TEAM
PRODUCTION OF MEDICINES IS STOPPED AND THERE WILL BE MONETARY IMPACT TO TUNE OF 75% OF TURNOVER OF ABOUT 60 MILLION RUPEES
Source text for Eikon: ID:nNSE6yZ5N7
Further company coverage: ORTN.NS
(([email protected];))
July 11 (Reuters) - Ortin Laboratories Ltd ORTN.NS:
DRUGS CONTROL ADMINISTRATION, GOVERNMENT OF TELANGANA CANCELLED CO’S MANUFACTURING LICENSE
CANCELLATION FORWANT OF UPGRADATION OF MANUFACTURING FACILITIES, INFRASTRUCTURE AND RECRUITING EXPERT TECHNICAL TEAM
PRODUCTION OF MEDICINES IS STOPPED AND THERE WILL BE MONETARY IMPACT TO TUNE OF 75% OF TURNOVER OF ABOUT 60 MILLION RUPEES
Source text for Eikon: ID:nNSE6yZ5N7
Further company coverage: ORTN.NS
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Ortin Global do?
Ortin Laboratories, known for quality drugs and medicines, operates a formulations unit meeting WHO GMP Standards. Certified for quality management, it markets products across India with good acceptance in the medical community.
Who are the competitors of Ortin Global?
Ortin Global major competitors are Hind Bio Science, Cian Healthcare, Senbo Industries, Secunderabad Health., iStreet Network, Kobo Biotech, Unjha Formulations. Market Cap of Ortin Global is ₹9 Crs. While the median market cap of its peers are ₹8 Crs.
Is Ortin Global financially stable compared to its competitors?
Ortin Global seems to be less financially stable compared to its competitors. Altman Z score of Ortin Global is -1.7 and is ranked 8 out of its 8 competitors.
Does Ortin Global pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ortin Global latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Ortin Global allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Ortin Global balance sheet?
Ortin Global balance sheet is weak and might have solvency issues
Is the profitablity of Ortin Global improving?
The profit is oscillating. The profit of Ortin Global is -₹4.83 Crs for TTM, -₹8.04 Crs for Mar 2024 and -₹0.09 Crs for Mar 2023.
Is the debt of Ortin Global increasing or decreasing?
Yes, The debt of Ortin Global is increasing. Latest debt of Ortin Global is -₹0.25 Crs as of Sep-24. This is greater than Mar-24 when it was -₹2.59 Crs.
Is Ortin Global stock expensive?
Ortin Global is not expensive. Latest PE of Ortin Global is 0.0, while 3 year average PE is 7.28. Also latest EV/EBITDA of Ortin Global is 0.0 while 3yr average is 28.09.
Has the share price of Ortin Global grown faster than its competition?
Ortin Global has given lower returns compared to its competitors. Ortin Global has grown at ~11.99% over the last 5yrs while peers have grown at a median rate of 19.59%
Is the promoter bullish about Ortin Global?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Ortin Global is 1.23% and last quarter promoter holding is 1.23%.
Are mutual funds buying/selling Ortin Global?
There is Insufficient data to gauge this.